BRVE
Braveheart Bio, Inc.
21.40$
+6.0%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
Braveheart Bio, Inc. (BRVE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -2.0 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2025 |
|---|---|
| -2.0 | |
| 0.2 | |
| 1.6 | |
| 34 | |
| 125 | |
| 89 | |
| -36 |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.